Skip to content

Compare Sacrocolpopexy Versus Laparoscopic Inguinal Ligament Hysteropexy for Uterus/Vagianl Vault Prolapse III/IV

Compare Sacrocolpopexy Versus Laparoscopic Inguinal Ligament Hysteropexy for Uterus/Vagianl Vault Prolapse III/IV

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-15007408
Enrollment
Unknown
Registered
2015-11-09
Start date
2015-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic floor disorder

Interventions

group A:laparoscopic inguinal ligament hysteropexy
group B:Sacrocolpopexy

Sponsors

Shanghai First Maternity and Infant Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Ages Eligible for Study from 18 Years to 80 Years; 2. Subject has been diagnosed with uterine prolapse or posthysterectomy vaginal vault prolapse (symptomatic POP-Q stage III or higher) requiring surgical repair; 3. Subject has no uncontrolled systemic disease; 4. Subject is unwilling or unable to give valid informed consent.

Exclusion criteria

Exclusion criteria: 1. Investigator determines subject is not a candidate for surgical repair of her genital prolapse (lack of symptomatic or imaging basis; 2. Subject has active or latent systemic disease (including server liver diseasekidney diseaserespiratory diseasecardiovascular diseaseepilepsy or uncontrolled diabetes; 3. Subject is currently pregnant or intends to become pregnant during the study period; 4. Subject has gynecological or other cancer; 5. Subject is on any medication with could result in compromised immune response, such as immune modulators; 6. Subject is unwilling or unable to give valid informed consent; 7. Subject is unwilling or unable to comply with the requirements of the protocol, complete all quality of Life questionnaires and return for all follow-up visits; 8. Subject with contraindications for laparoscopy.

Design outcomes

Primary

MeasureTime frame
POP-Q;pelvic MRI;

Countries

China

Contacts

Public ContactZhiyuan Dai
daizhiyuan@51mch.com+86 18964535689

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 24, 2026